Innov Clin Neurosci. 2025;22(1–3):11–13. Dear Editor: Emerging data on sex differences in the efficacy and tolerability of antipsychotics in patients with schizophrenia are not taken into account in current guidelines,
Innov Clin Neurosci. 2024;21(10–12):8. Dear Editor: The interesting article by Zuckerberg et al1 on a 29-year-old male patient with schizophrenia, catatonia, and stupor associated with an enlarged cavum septum pellucidum
Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Citrome is a consultant for AbbVie/Allergan, Acadia, Adamas, Alkermes, Angelini, Astellas, Avanir, Axsome, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Cerevel, Clinilabs, COMPASS, Eisai, Enteris
Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Zaragoza Domingo is co-author and intellectual property owner of the EPICOG-SCH battery. No funding was received for the preparation of this letter. Dear
by Mark G. A. Opler, PhD, MPH; Amy Claxton, PhD*; James McGrory, PhD; Sabina Gasper, MPH*; Meihua Wang, PhD*; and Sergey Yagoda, MD, PhD Dr. Opler is with WCG, Inc.
by Allison Zuckerberg, MD; Nitin Pothen, MD; and Adriana Fitzsimmons, MD Dr. Zuckerberg is with Department of Psychiatry, Temple University Hospital in Philadelphia, Pennsylvania. Dr. Pothen is with Department of
by Leslie Citrome, MD, MPH; Marko A. Mychaskiw, BSRPh, MS, PhD; Alma Cortez, BA; Mark Opler, MPH, PhD; Liza Sopina, MPH, PhD; and Sameer Kotak, MS, MBA Dr. Citrome is
Funding/financial disclosures. The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2023;20(4–6):9–10.
by Alok Singh, MD Dr. Singh is with All India Institute of Medical Sciences in Raipur, India. Funding: No funding was provided for this study. Disclosures: The author has no
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital in Hiroshima, Japan. Dr. Nagamine is with the
by JP Lindenmayer, MD; Beverly J. Insel, PhD; Anzalee Khan, PhD; McKenzie Osborne, BA; Abraham Goldring, MA; and Mary Seddo, BA Drs. Lindenmayer, Insel, and Khan, Ms. Osborne and Seddo,
by Rajashekar Reddy Yeruva, MD; Yafei Shang, MD; Ben Schoenbachler, MD; Sharon Nuss, MS; and Rif S El-Mallakh, MD Dr. Yeruva is with Baylor Scott and White Medical Center in
by Philip D. Harvey, PhD; Michelle L. Miller, MS; Raeanne C. Moore, PhD; Colin A. Depp, PhD; Emma M. Parrish, BS; and Amy E. Pinkham, PhD Dr. Harvey is with
Dear Editor: A number of hypotheses have been put forth regarding the etiology of schizophrenia, including dopamine hypothesis and glutamate hypothesis.1 However, a lesser known theory is that elevated norepinephrinergic
by Charisse Chehovich, PharmD; Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; Emily Leppien, PharmD, BCPS; and Eileen Trigoboff, RN, PMHCNS-BC, DNS, DABFN Drs. Chehovich, Demler, and Trigoboff are affiliated
by Paul C. McCormick, Jr., MD, and Jessica Simberlund, MD Drs. McCormick and Simberlund are with the Department of Psychiatry at Weill Cornell Medicine and the New York-Presbyterian Hospital in
by David G. Daniel, MD; Alan Kott, MD; Jay Saoud, Phd; Remy Luthringer, PhD; Vadym Rud, MD, PhD; Andrii Skyrpnikov, MD, PhD; Rodica Stan, MD, PhD; Veselin Palazov, MD; Xingmei
by Takashi Ohnishi, MD, PhD; Hisanori Kobayashi, PhD; Toshio Yamaoka; Tokiko Toma; Keiko Imai; Akihide Wakamatsu; and Kenichi Noguchi, PhD Drs. Ohnishi, Kobayashi, and Noguchi and Mr. Wakamatsu are with
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital in Hiroshima, Japan. Dr. Nagamine is with the
by Leslie Citrome, MD, MPH; Stephanie S. O’Malley, PhD; David McDonnell, MD; Ying Jiang, PhD; Adam C. Simmons, MPH; Mark P. Berry; and Lauren E. DiPetrillo, PhD Dr. Citrome is
